# Vafseo Outcomes In-Center Experience

> **NCT06520826** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **USRC Kidney Research** · enrollment: 2200 (estimated)

## Conditions studied

- Anemia of Chronic Kidney Disease

## Interventions

- **DRUG:** Vadadustat
- **DRUG:** Erythropoiesis Stimulating Agent

## Key facts

- **NCT ID:** NCT06520826
- **Lead sponsor:** USRC Kidney Research
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06520826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06520826, "Vafseo Outcomes In-Center Experience". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06520826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*